Gluteal hemangioma mimicking a neuroendocrine tumor: pitfalls in neuroendocrine tumor diagnostic testing. [PDF]
Braunstein GD +5 more
europepmc +1 more source
Somatostatin and Its Analogues as Second-Line Treatments in Non-Neoplastic Conditions. [PDF]
Periferakis A +10 more
europepmc +1 more source
Octreotide Counteracts IFN-γ-Induced Endothelial Inflammation. [PDF]
Fakir S +3 more
europepmc +1 more source
Partial restoration of counterregulatory circulating glucagon by dapagliflozin and low-dose glibenclamide in men with type 1 diabetes: in vitro studies and randomised clinical crossover trial. [PDF]
Gao R +10 more
europepmc +1 more source
Distinct Activity Profiles of Somatostatin-Expressing Interneurons in the Neocortex
Srikanth Ramaswamy +2 more
doaj +1 more source
Efficacy and safety of octreotide versus somatostatin therapy after CRS + HIPEC in patients with peritoneal carcinomatosis. [PDF]
Li B, Ji ZH, Liu G, Yu Y, Li Y.
europepmc +1 more source
What is the future of acromegaly therapy?
Schilbach K, Strasburger CJ.
europepmc +1 more source
Small bowel obstruction from metastatic small intestinal neuroendocrine tumor managed solely with somatostatin analog. [PDF]
Taher Z, Andijani R, Radi S.
europepmc +1 more source
Pathogenesis of nonfamilial somatotroph adenomas.
Ben-Shlomo A, Melmed S.
europepmc +1 more source
Combination therapy of pasireotide and pegvisomant for aggressive acromegaly with an immature PIT1-lineage PitNET. [PDF]
Tomiyama K +5 more
europepmc +1 more source

